Peptide nucleic acids targeting miR-221 modulate p27Kip1 expression in breast cancer MDA-MB-231 cells

International Journal of Oncology

Volumn 41, Issue 6, 2012, Pages 2119-2127

  Brognara, Eleonora ^a   Fabbri, Enrica ^a   Aimi, Fabio ^b   Manicardi, Alex ^b   Bianchi, Nicoletta ^a   Finotti, Alessia ^a   Breveglieri, Giulia ^a   Borgatti, Monica ^a   Corradini, Roberto ^b   Marchelli, Rosangela ^b   Gambari, Roberto ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

Author keywords

Delivery; microRNAs; miR 221; p27kip1; Peptide nucleic acids

Indexed keywords

DRUG CARRIER; MICRORNA 221; PEPTIDE NUCLEIC ACID; PEPTIDE NUCLEIC ACID A221; POLYARGININE; PROTEIN P27; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; BINDING AFFINITY; BREAST CANCER; CANCER CELL; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG UPTAKE; HUMAN; HUMAN CELL; HYBRIDIZATION; IC 50; IN VITRO STUDY; METASTASIS POTENTIAL; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA BINDING; RNA EXTRACTION; RNA ISOLATION; WESTERN BLOTTING;

BASE SEQUENCE; BREAST NEOPLASMS; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE INHIBITOR P27; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE ORDER; HUMANS; MICRORNAS; PEPTIDE NUCLEIC ACIDS; RNA INTERFERENCE;

EID: 84869857955     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2012.1632     Document Type: Article

References (52)

1. Filipowicz W, Jaskiewicz L, Kolb FA and Pillai RS: Post-transcriptional gene silencing by siRNAs and miRNAs. Curr Opin Struct Biol 15: 331-341, 2005. (Pubitemid 40826453)
2. He L and Hannon GJ: MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 5: 522-531, 2010.
3. Kozomara A and Griffiths-Jones S: miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res 39: D152-D157, 2011.
4. Krol J, Loedige I and Filipowicz W: The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 11: 597-610, 2010.
5. Cho WCS: OncomiRs: the discovery and progress of microRNAs in cancers. Mol Cancer 6: 60, 2007.
6. Edmonds MD, Hurst DR and Welch DR: Linking metastasis suppression with metastamiR regulation. Cell Cycle 17: 2673-2675, 2009.
7. Shah MY and Calin GA: MicroRNAs miR-221 and miR-222: a new level of regulation in aggressive breast cancer. Genome Med 3: 56-68, 2011.
8. Zhang CZ, Zhang JX, Zhang AL, et al: MiR-221 and miR-222 target PUMA to induce cell survival in glioblastoma. Mol Cancer 9: 229, 2010.
9. Fu X, Wang Q, Chen J, et al: Clinical significance of miR-221 and its inverse correlation with p27Kip1 in hepatocellular carcinoma. Mol Biol Rep 38: 3029-3035, 2011.
10. Park JK, Lee EJ, Esau C and Schmittgen TD: Antisense inhibition of microRNA-21 or -221 arrests cell cycle, induces apoptosis, and sensitizes the effects of gemcitabine in pancreatic adenocarcinoma. Pancreas 38: e190-e199, 2009.
11. Kanemaru H, Fukushima S, Yamashita J, et al: The circulating microRNA-221 level in patients with malignant melanoma as a new tumor marker. J Dermatol Sci 3: 187-193, 2011.
12. Frenquelli M, Muzio M, Scielzo C, et al: MicroRNA and proliferation control in chronic lymphocytic leukemia: functional relationship between miR-221/222 cluster and p27. Blood 19: 3949-3959, 2010.
13. Visone R, Russo L, Pallante P, et al: MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle. Endocr Relat Cancer 14: 791-798, 2007. (Pubitemid 350074067)
14. Zheng C, Yinghao S and Li J: MiR-221 expression affects invasion potential of human prostate carcinoma cell lines by targeting DVL2. Med Oncol 29: 815-822, 2012.
15. Zhang C, Zhang J, Zhang A, Wang Y, Han L, You Y, Pu P and Kang C: PUMA is a novel target of miR-221/222 in human epithelial cancers. Int J Oncol 6: 1621-1626, 2010.
16. Chun-Zhi Z, Lei H, An-Ling Z, et al: MicroRNA-221 and microRNA-222 regulate gastric carcinoma cell proliferation and radioresistance by targeting PTEN. BMC Cancer 10: 367, 2010.
17. Lu X, Zhao P, Zhang C, et al: Analysis of miR-221 and p27 expression in human gliomas. Mol Med Rep 4: 651-656, 2009.
18. kip1 in vitro and in vivo. Int J Oncol 34: 1653-1660, 2009.
19. Le Sage C, Nagel R, Egan DA, et al: Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation. EMBO J 26: 3699-3708, 2007. (Pubitemid 47236875)
20. Galardi S, Mercatelli N, Giorda E, Massalini S, Frajese GV, Ciafrè SA and Farace MG: miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1. J Biol Chem 282: 23716-23724, 2007. (Pubitemid 47311902)
21. Marin VL, Roy S and Armitage BA: Recent advances in the development of peptide nucleic acid as a gene-targeted drug. Expert Opin Biol Ther 4: 337-348, 2004. (Pubitemid 38352130)
22. Pession A, Tonelli R, Fronza R, et al: Targeted inhibition of NMYC by peptide nucleic acid (PNA) in N-myc amplified human neuroblastoma cells: cell-cycle inhibition with induction of neuronal cell differentiation and apoptosis. Int J Oncol 24: 265-272, 2004.
23. Gambari R: Biological activity and delivery of peptide nucleic acids (PNA)-DNA chimeras for transcription factor decoy (TFD) pharmacotherapy. Curr Med Chem 11: 1253-1263, 2004.
24. Nielsen PE, Egholm M, Berg RH and Buchardt O: Sequence-selective recognition of DNA by strand displacement with a thymine-substituted polyamide. Science 254: 1497-1500, 1991. (Pubitemid 21917487)
25. Nastruzzi C, Cortesi R, Esposito E, et al: Liposomes as carriers for DNA-PNA hybrids. J Control Release 68: 237-249, 2000. (Pubitemid 30488901)
26. Paulasova P and Pellestor F: The peptide nucleic acids (PNAs): a new generation of probes for genetic and cytogenetic analyses. Ann Genet 47: 349-358, 2004. (Pubitemid 39575613)
27. Karkare S and Bhatnagar D: Promising nucleic acid analogs and mimics: characteristic features and applications of PNA, LNA, and morpholino. Appl Microbiol Biotechnol 71: 575-586, 2006. (Pubitemid 44114786)
28. Menchise V, De Simone G, Tedeschi T, et al: Insights into peptide nucleic acid (PNA) structural features: the crystal structure of a D-lysine-based chiral PNA-DNA duplex. Proc Natl Acad Sci USA 100: 12021-12026, 2003. (Pubitemid 37271508)
29. Nielsen PE: Antisense peptide nucleic acids. Curr Opin Mol Ther 2: 282-287, 2000.
30. Soomets U, Hällbrink M and Langel U: Antisense properties of peptide nucleic acids. Front Biosci 4: D782-D786, 1999.
31. Ray A and Nordén B: Peptide nucleic acid (PNA): its medical and biotechnical applications and promise for the future. FASEB J 14: 1041-1060, 2000. (Pubitemid 30350386)
32. Tonelli R, Purgato S, Camerin C, Fronza S, et al: Anti-gene peptide nucleic acid specifically inhibits MYCN expression in human neuroblastoma cells leading to persistent cell growth inhibition and apoptosis. Mol Cancer Ther 4: 779-786, 2005. (Pubitemid 40767122)
33. Nielsen PE: Targeting double stranded DNA with peptide nucleic acid (PNA). Curr Med Chem 8: 545-550, 2001.
34. Borgatti M, Lampronti I, Romanelli A, et al: Transcription factor decoy molecules based on a peptide nucleic acid (PNA)-DNA chimera mimicking Sp1 binding sites. J Biol Chem 278: 7500-7509, 2003. (Pubitemid 36800757)
35. Rasmussen FW, Bendifallah N, Zachar V, et al: Evaluation of transfection protocols for unmodified and modified peptide nucleic acid (PNA) oligomers. Oligonucleotides 16: 43-57, 2006.
36. Cortesi R, Mischiati C, Borgatti M, et al: Formulations for natural and peptide nucleic acids based on cationic polymeric submicron particles. AAPS J 6: 10-21, 2004.
37. Borgatti M, Breda L, Cortesi R, et al: Cationic liposomes as delivery systems for double-stranded PNA-DNA chimeras exhibiting decoy activity against NF-kappaB transcription factors. Biochem Pharmacol 64: 609-616, 2002.
38. Abes R, Arzumanov A, Moulton H, et al: Arginine-rich cell penetrating peptides: design, structureactivity, and applications to alter pre-mRNA splicing by steric-block oligonucleotides. J Pept Sci 14: 455-460, 2008. (Pubitemid 351540906)
39. Torres AG, Threlfall RN and Gait MJ: Potent and sustained cellular inhibition of miR-122 by lysine-derivatized peptide nucleic acids (PNA) and phosphorothioate locked nucleic acid (LNA)/2′-O-methyl (OMe) mixmer anti-miRs in the absence of transfection agents. Artificial DNA PNA XNA 2: 71-78, 2011.
40. Fabani MM and Gait MJ: miR-122 targeting with LNA/2′-O-methyl oligonucleotide mixmers, peptide nucleic acids (PNA), and PNA-peptide conjugates. RNA 14: 336-346, 2008. (Pubitemid 351171593)
41. Fabani MM, Abreu-Goodger C, Williams D, et al: Efficient inhibition of miR-155 function in vivo by peptide nucleic acids. Nucleic Acids Res 38: 4466-4475, 2010.
42. Yan LX, Wu QN, Zhang Y, et al: Knockdown of miR-21 in human breast cancer cell lines inhibits proliferation, in vitro migration and in vivo tumor growth. Breast Cancer Res 13: R2, 2011.
43. Bianchi N, Zuccato C, Lampronti I, Borgatti M and Gambari R: Expression of miR-210 during erythroid differentiation and induction of gamma-globin gene expression. BMB Rep 42: 493-499, 2009.
44. Fabbri E, Manicardi A, Tedeschi T, et al: Modulation of the biological activity of microRNA-210 with peptide nucleic acids (PNAs). Chem Med Chem 6: 2192-2202, 2011.
45. Mizuma M, Katayose Y, Yamamoto K, et al: Up-regulated p27Kip1 reduces matrix metalloproteinase-9 and inhibits invasion of human breast cancer cells. Anticancer Res 28 (5A): 2669-2677, 2008.
46. Manicardi A, Calabretta A, Bencivenni M, Tedeschi T, Sforza S, Corradini R and Marchelli R: Affinity and selectivity of C2- and C5-substituted 'chiral-box' PNA in solution and on microarrays. Chirality 22 (Suppl 1): E161-E172, 2010.
47. Cailleau R, Olivé M and Cruciger QV: Long-term human breast carcinoma cell lines of metastatic origin: preliminary characterization. In Vitro 14: 911-915, 1978. (Pubitemid 9089089)
48. Brown I, Shalli K, McDonald SL, Moir SE, Hutcheon AW, Heys SD and Schofield AC: Reduced expression of p27 is a novel mechanism of docetaxel resistance in breast cancer cells. Breast Cancer Res 6: R601-R607, 2004.
49. Faccini A, Tortori A, Tedeschi T, et al: Circular dichroism study of DNA binding by a potential anticancer peptide nucleic acid targeted against the MYCN oncogene. Chirality 20: 494-500, 2008. (Pubitemid 351303990)
50. Suzuki T, Wu D, Schlachetzki F, Li JY, Boado RJ and Pardridge WM: Imaging endogenous gene expression in brain cancer in vivo with 111In-peptide nucleic acid antisense radiopharmaceuticals and brain drug-targeting technology. J Nucl Med 45: 1766-1775, 2004. (Pubitemid 47618489)
51. Pardridge WM, Boado RJ and Kang YS: Vector-mediated delivery of a polyamide ('peptide') nucleic acid analogue through the blood-brain barrier in vivo. Proc Natl Acad Sci USA 92: 5592-5596, 1995.
52. Adlerz L, Soomets U, Holmlund L, Viirlaid S, Langel U and Iverfeldt K: Down-regulation of amyloid precursor protein by peptide nucleic acid oligomer in cultured rat primary neurons and astrocytes. Neurosci Lett 336: 55-59, 2003. (Pubitemid 35454120)